33 related articles for article (PubMed ID: 34751832)
1. Whole-Body Disposition and Physiologically Based Pharmacokinetic Modeling of Adeno-Associated Viruses and the Transgene Product.
Liu S; Chowdhury EA; Xu V; Jerez A; Mahmood L; Ly BQ; Le HK; Nguyen A; Rajwade A; Meno-Tetang G; Shah DK
J Pharm Sci; 2024 Jan; 113(1):141-157. PubMed ID: 37805073
[TBL] [Abstract][Full Text] [Related]
2.
Isoherranen N
Drug Metab Dispos; 2024 Feb; ():. PubMed ID: 38326033
[TBL] [Abstract][Full Text] [Related]
3. Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine.
Shen L; Li Z; Ma A; Cruz-Teran C; Talkington A; Shipley ST; Lai SK
ACS Nano; 2024 Mar; 18(12):8733-8744. PubMed ID: 38469811
[TBL] [Abstract][Full Text] [Related]
4. Local Identifiability Analysis, Parameter Subset Selection and Verification for a Minimal Brain PBPK Model.
Dadashova K; Smith RC; Haider MA
Bull Math Biol; 2024 Jan; 86(2):12. PubMed ID: 38170402
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach.
Cheng YH; He C; Riviere JE; Monteiro-Riviere NA; Lin Z
ACS Nano; 2020 Mar; 14(3):3075-3095. PubMed ID: 32078303
[TBL] [Abstract][Full Text] [Related]
6. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice.
Chou WC; Chen Q; Yuan L; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE; Lin Z
J Control Release; 2023 Sep; 361():53-63. PubMed ID: 37499908
[TBL] [Abstract][Full Text] [Related]
7. Multiphysics pharmacokinetic model for targeted nanoparticles.
Glass EM; Kulkarni S; Eng C; Feng S; Malaviya A; Radhakrishnan R
Front Med Technol; 2022; 4():934015. PubMed ID: 35909883
[TBL] [Abstract][Full Text] [Related]
8. Is PBPK useful to inform product label on managing clinically significant drug interactions mediated by cytokine release syndrome?
Zhang X; Zhao P
CPT Pharmacometrics Syst Pharmacol; 2024 Jun; ():. PubMed ID: 38866079
[No Abstract] [Full Text] [Related]
9. The power of weak, transient interactions across biology: A paradigm of emergent behavior.
Vasquez PA; Walker B; Bloom K; Kolbin D; Caughman N; Freeman R; Lysy M; Hult C; Newhall KA; Papanikolas M; Edelmaier C; Forest MG
Physica D; 2023 Nov; 454():. PubMed ID: 38274029
[TBL] [Abstract][Full Text] [Related]
10. A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse.
McSweeney MD; Wessler T; Price LSL; Ciociola EC; Herity LB; Piscitelli JA; Zamboni WC; Forest MG; Cao Y; Lai SK
J Control Release; 2018 Aug; 284():171-178. PubMed ID: 29879519
[TBL] [Abstract][Full Text] [Related]
11. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
12. Physiologically Based Pharmacokinetic Modeling of Therapeutic Proteins.
Wong H; Chow TW
J Pharm Sci; 2017 Sep; 106(9):2270-2275. PubMed ID: 28392453
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles.
Kumar M; Kulkarni P; Liu S; Chemuturi N; Shah DK
Adv Drug Deliv Rev; 2023 Mar; 194():114708. PubMed ID: 36682420
[TBL] [Abstract][Full Text] [Related]
14. Experimental Data and PBPK Modeling Quantify Antibody Interference in PEGylated Drug Carrier Delivery.
Talkington AM; Wessler T; Lai SK; Cao Y; Forest MG
Bull Math Biol; 2021 Nov; 83(12):123. PubMed ID: 34751832
[TBL] [Abstract][Full Text] [Related]
15. A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes.
Talkington AM; McSweeney MD; Wessler T; Rath MK; Li Z; Zhang T; Yuan H; Frank JE; Forest MG; Cao Y; Lai SK
J Control Release; 2022 Mar; 343():518-527. PubMed ID: 35066099
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
